|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/68 | (2006.01) |
| G01N 33/587 | (2013.01) | ||
| G01N 33/58 | (2006.01) | ||
| G01N 33/6845 | (2013.01) |
| (11) | Number of the document | 3761035 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20191942.0 |
| Date of filing the European patent application | 2017-08-18 | |
| (97) | Date of publication of the European application | 2021-01-06 |
| (45) | Date of publication and mention of the grant of the patent | 2024-02-14 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201662376788 P | 2016-08-18 | US |
| (72) |
MARLOW, Michael , US
SENNETT, Michael , US
SCHNEIDER, Michael , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | ASSAY FOR DETERMINING POTENTIAL TO SELF-ASSOCIATION OF A PROTEIN USING CONCENTRATION-DEPENDENT SELF-INTERACTION NANOPARTICLE SPECTROSCOPY |
| ASSAY FOR DETERMINING POTENTIAL TO SELF-ASSOCIATION OF A PROTEIN USING CONCENTRATION-DEPENDENT SELF-INTERACTION NANOPARTICLE SPECTROSCOPY |